» Articles » PMID: 14525931

High-throughput Selection of Effective RNAi Probes for Gene Silencing

Overview
Journal Genome Res
Specialty Genetics
Date 2003 Oct 4
PMID 14525931
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

RNA interference (RNAi) is a process of sequence-specific posttranscriptional gene silencing mediated by double-stranded RNA. RNAi has recently emerged as a powerful genetic tool to analyze gene function in mammalian cells. The power of this method is limited however, by the uncertainty in predicting the efficacy of small interfering RNAs (siRNAs) in silencing a gene. This has imposed serious limitations not only for small-scale but also for high-throughput RNAi screening initiatives in mammalian systems. We have developed a reliable and quantitative approach for the rapid and efficient identification of the most effective siRNA against any gene. The efficacy of siRNA sequences is monitored by their ability to reduce the expression of cognate target-reporter fusions with easily quantified readouts. Finally, using micro array-based cell transfections, we demonstrate an unlimited potential of this approach in high-throughput screens for identifying effective siRNA probes for silencing genes in mammalian systems. This approach is likely to have implications in the use of RNAi as a reverse genetic tool for analyzing mammalian gene function on a genome-wide scale.

Citing Articles

Lipid-Based Nanocarriers in Renal RNA Therapy.

Su C, See D, Huang J Biomedicines. 2022; 10(2).

PMID: 35203492 PMC: 8869454. DOI: 10.3390/biomedicines10020283.


Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis.

Pan M, Li M, Guo M, Zhou H, Xu H, Zhao F Exp Ther Med. 2021; 22(4):1093.

PMID: 34504547 PMC: 8383762. DOI: 10.3892/etm.2021.10527.


RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells.

Lou B, Connor K, Sweeney K, Miller I, OFarrell A, Ruiz-Hernandez E Drug Deliv Transl Res. 2019; 9(3):679-693.

PMID: 30972664 DOI: 10.1007/s13346-019-00637-y.


Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension.

Shaffi S, Galas D, Etheridge A, Argyropoulos C Int J Mol Sci. 2018; 19(6).

PMID: 29914215 PMC: 6032378. DOI: 10.3390/ijms19061797.


A database of breast oncogenic specific siRNAs.

Tyagi A, Semwal M, Sharma A Sci Rep. 2017; 7(1):8706.

PMID: 28821760 PMC: 5562753. DOI: 10.1038/s41598-017-08948-1.


References
1.
Bernstein E, Caudy A, Hammond S, Hannon G . Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature. 2001; 409(6818):363-6. DOI: 10.1038/35053110. View

2.
Sharp P . RNAi and double-strand RNA. Genes Dev. 1999; 13(2):139-41. View

3.
Gil J, Esteban M . Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis. 2001; 5(2):107-14. DOI: 10.1023/a:1009664109241. View

4.
Hammond S, Caudy A, Hannon G . Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet. 2001; 2(2):110-9. DOI: 10.1038/35052556. View

5.
Simpson J, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S . Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep. 2001; 1(3):287-92. PMC: 1083732. DOI: 10.1093/embo-reports/kvd058. View